[1]
|
The Lancet (2024) What Next in Parkinson’s Disease? The Lancet, 403, 219. https://doi.org/10.1016/S0140-6736(24)00094-1
|
[2]
|
Webb, J.L., Ravikumar, B., et al. (2003) Alpha-Synuclein Is Degraded by both Autophagy and the Proteasome. Journal of Biological Chemistry, 278, 25009-25013. https://doi.org/10.1074/jbc.M300227200
|
[3]
|
Xu, H. and Ren, D. (2015) Lysosomal Physiology. Annual Review of Physiology, 77, 57-80. https://doi.org/10.1146/annurev-physiol-021014-071649
|
[4]
|
Butor, C., Griffiths, G., et al. (1995) Co-Localization of Hydrolytic Enzymes with Widely Disparate pH Optima: Implications for the Regulation of Lysosomal pH. Journal of Cell Science, 108, 2213-2219. https://doi.org/10.1242/jcs.108.6.2213
|
[5]
|
Mindell, J.A. (2012) Lysosomal Acidification Mechanisms. Annual Review of Physiology, 74, 69-86. https://doi.org/10.1146/annurev-physiol-012110-142317
|
[6]
|
Hu, M.Q., et al. (2024) The Ion Channels of Endomembranes. Physiological Reviews, 104, 1335-1385.
|
[7]
|
Hu, M., Li, P., Wang, C., et al. (2022) Parkinson’s Disease-Risk Protein TMEM175 Is a Proton-Activated Proton Channel in Lysosomes. Cell, 185, 2292-2308.E20. https://doi.org/10.1016/j.cell.2022.05.021
|
[8]
|
Gibb, W.R. and Lees, A.J. (1988) The Relevance of the Lewy Body to the Pathogenesis of Idiopathic Parkinson’s Disease. Journal of Neurology, Neurosurgery & Psychiatry, 51, 745-752. https://doi.org/10.1136/jnnp.51.6.745
|
[9]
|
Tozzi, A., Sciaccaluga, M., Loffredo, V., et al. (2021) Dopamine-Dependent Early Synaptic and Motor Dysfunctions Induced by α-Synuclein in the Nigrostriatal Circuit. Brain, 144, 3477-3491. https://doi.org/10.1093/brain/awab242
|
[10]
|
Calo, L., Wegrzynowicz, M., Santivanez-Perez, J., et al. (2016) Synaptic Failure and Alpha-Synuclein. Movement Disorders, 31, 169-177. https://doi.org/10.1002/mds.26479
|
[11]
|
Schweighauser, M., et al. (2020) Structures of α-Synuclein Filaments from Multiple System Atrophy. Nature, 585, 464-469. https://doi.org/10.1038/s41586-020-2317-6
|
[12]
|
Morris, H.R., Spillantini, M.G., Sue, C.M., et al. (2024) The Pathogenesis of Parkinson’s Disease. The Lancet, 403, 293-304. https://doi.org/10.1016/S0140-6736(23)01478-2
|
[13]
|
Guo, Y., Sun, Y., Song, Z., et al. (2021) Genetic Analysis and Literature Review of SNCA Variants in Parkinson’s Disease. Frontiers in Aging Neuroscience, 13, Article ID: 648151. https://doi.org/10.3389/fnagi.2021.648151
|
[14]
|
Ben-Shlomo, Y., Darweesh, S., Llibre-Guerra, J., et al. (2024) The Epidemiology of Parkinson’s Disease. The Lancet, 403, 283-292. https://doi.org/10.1016/S0140-6736(23)01419-8
|
[15]
|
Horowitz, M., Braunstein, H., Zimran, A., et al. (2022) Lysosomal Functions and Dysfunctions: Molecular and Cellular Mechanisms Underlying Gaucher Disease and Its Association with Parkinson Disease. Advanced Drug Delivery Reviews, 187, Article ID: 114402. https://doi.org/10.1016/j.addr.2022.114402
|
[16]
|
Navarro-Romero, A., Montpeyo, M. and Martinez-Vicente, M. (2020) The Emerging Role of the Lysosome in Parkinson’s Disease. Cells, 9, Article No. 2399. https://doi.org/10.3390/cells9112399
|
[17]
|
Vogiatzi, T., Xilouri, M., et al. (2008) Wild Type Alpha-Synuclein Is Degraded by Chaperone-Mediated Autophagy and Macroautophagy in Neuronal Cells. Journal of Biological Chemistry, 283, 23542-23556. https://doi.org/10.1074/jbc.M801992200
|
[18]
|
Dehay, B., Martinez-Vicente, M., et al. (2013) Lysosomal Impairment in Parkinson’s Disease. Movement Disorders, 28, 725-732. https://doi.org/10.1002/mds.25462
|
[19]
|
Dehay, B., Ramirez, A., et al. (2012) Loss of P-Type ATPase ATP13A2/PARK9 Function Induces General Lysosomal Deficiency and Leads to Parkinson Disease Neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America, 109, 9611-9616. https://doi.org/10.1073/pnas.1112368109
|
[20]
|
Schultheis, P.J., Fleming, S., et al. (2013) Atp13a2-Deficient Mice Exhibit Neuronal Ceroid Lipofuscinosis, Limited α-Synuclein Accumulation and Age-Dependent Sensorimotor Deficits. Human Molecular Genetics, 22, 2067-2082. https://doi.org/10.1093/hmg/ddt057
|
[21]
|
Wallings, R., Connor-Robson, N. and Wade-Martins, R. (2019) LRRK2 Interacts with the Vacuolar-Type H -ATPase Pump A1 Subunit to Regulate Lysosomal Function. Human Molecular Genetics, 28, 2696-2710. https://doi.org/10.1093/hmg/ddz088
|
[22]
|
Henry, A.G., Aghamohammadzadeh, S., Samaroo, H., et al. (2015) Pathogenic LRRK2 Mutations, through Increased Kinase Activity, Produce Enlarged Lysosomes with Reduced Degradative Capacity and Increase ATP13A2 Expression. Human Molecular Genetics, 24, 6013-6028. https://doi.org/10.1093/hmg/ddv314
|
[23]
|
Dehay, B., BovE, J., et al. (2010) Pathogenic Lysosomal Depletion in Parkinson’s Disease. Journal of Neuroscience, 30, 12535-12544. https://doi.org/10.1523/JNEUROSCI.1920-10.2010
|
[24]
|
Vest, R.T., Chou, C.C., Zhang, H., et al. (2022) Small Molecule C381 Targets the Lysosome to Reduce Inflammation and Ameliorate Disease in Models of Neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America, 119, E2121609119. https://doi.org/10.1073/pnas.2121609119
|
[25]
|
Rahman, N., Ramos-Espiritu, L., Milner, T.A., et al. (2016) Soluble Adenylyl Cyclase Is Essential for Proper Lysosomal Acidification. Journal of General Physiology, 148, 325-339. https://doi.org/10.1085/jgp.201611606
|
[26]
|
Bonam, S.R., Wang, F. and Muller, S. (2019) Lysosomes as a Therapeutic Target. Nature Reviews Drug Discovery, 18, 923-948. https://doi.org/10.1038/s41573-019-0036-1
|
[27]
|
Tong, B.C., Huang, A.S., Wu, A.J., et al. (2022) Tetrandrine Ameliorates Cognitive Deficits and Mitigates Tau Aggregation in Cell and Animal Models of Tauopathies. Journal of Biomedical Science, 29, Article No. 85. https://doi.org/10.1186/s12929-022-00871-6
|
[28]
|
Yao, X.C., Xue, X., Zhang, H.T., et al. (2019) Pseudoginsenoside-F11 Alleviates Oligomeric β-Amyloid-Induced Endosome-Lysosome Defects in Microglia. Traffic, 20, 61-70. https://doi.org/10.1111/tra.12620
|
[29]
|
Chin, M., Ang, K.H., Davies, J., et al. (2022) Phenotypic Screening Using High-Content Imaging to Identify Lysosomal pH Modulators in a Neuronal Cell Model. ACS Chemical Neuroscience, 13, 1505-1516. https://doi.org/10.1021/acschemneuro.1c00804
|
[30]
|
Bordi, M., Berg, M.J., Mohan, P.S., et al. (2016) Autophagy Flux in CA1 Neurons of Alzheimer Hippocampus: Increased Induction Overburdens Failing Lysosomes to Propel Neuritic Dystrophy. Autophagy, 12, 2467-2483. https://doi.org/10.1080/15548627.2016.1239003
|
[31]
|
Lo, C.H., Skarica, M., Mansoor, M., et al. (2021) Astrocyte Heterogeneity in Multiple Sclerosis: Current Understanding and Technical Challenges. Frontiers in Cellular Neuroscience, 15, Article ID: 726479. https://doi.org/10.3389/fncel.2021.726479
|